RETINOPATHY

Clinical trials for RETINOPATHY explained in plain language.

Never miss a new study

Get alerted when new RETINOPATHY trials appear

Sign up with your email to follow new studies for RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Could an allergy drug shield diabetics from organ damage?

Disease control Not yet recruiting

This study tests whether montelukast, a common allergy medication, can reduce damage to the kidneys, eyes, and blood vessels in adults with type 2 diabetes and early kidney disease. The drug works by blocking inflammatory chemicals called leukotrienes, which are linked to diabete…

Matched conditions: RETINOPATHY

Phase: PHASE4 • Sponsor: University of Colorado, Denver • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

RETINOPATHY

Get alerted when new RETINOPATHY trials appear

Could an allergy drug shield diabetics from organ damage?